Kevin O’Brien is an investor and board member at EmOpti Inc, a founder-led tele-health business focused on workflow improvements in health systems and Memorial MRI, a Texas-based freestanding imaging center and interventional pain business. He is also an advisor to the U.S. Diplomatic Studies Foundation, a 501(c)(3) focused on supporting and enhancing the educational and training needs of U.S. government departments and organizations through innovative programs.
In 2021 he retired from CCMP Capital Advisors, LP, a New York-based private equity firm where, over the previous 21 years, he was a Managing Director leading the healthcare practice and a member of its Investment Committee. Mr. O’Brien was deeply involved in, and served on the board of CCMP investments including Eating Recovery Centers (behavioral treatment for eating and related disorders), CareMore Medical Enterprises (Medicare Advantage health plan), LHP Hospital Group (short-term acute care hospital company focused on JVs with larger health systems), Medpace (contract research organization focused on human trials primarily for biotech companies), National Surgical Care (ambulatory surgery centers), Infogroup (marketing data services), and La Petite Academy (early childhood education).
Prior to joining JP Morgan Partners in 2000, CCMP’s predecessor firm, Mr. O’Brien worked in investment banking in the high yield capital markets and banking groups at Chase Securities and Chemical Securities. Prior to that, he was a Commissioned Officer in the U.S. Navy where he served as a Surface Warfare Officer from 1988 to 1992.
Mr. O’Brien holds a B.A. from the University of Notre Dame and an M.B.A. from the Wharton School of the University of Pennsylvania.